News & Perspective

Oct 04, 2019

Oct 04, 2019

ASP Scan (Weekly) for Oct 04, 2019

Resistant urinary tract infections
Rapid diagnostic test data
New antibiotic vs gram-neg pneumonia
FDA review of kids' C diff treatment
MRSA nasal screening
MDR Acinetobacter baumannii pneumonia
Fluoroquinolone stewardship
Trial of new gonorrhea antibiotic
Rapid viral diagnostics trial

Aug 16, 2019

Aug 16, 2019

ASP Scan (Weekly) for Aug 16, 2019

Funding for Staph vaccine
Delafloxacin-resistant MRSA
Antibiotic resistance in Europe
Antibiotic pipeline gaps
Antibiotic resistance legislation
Urinary tract infection treatment
Combo therapy for MRSA infections
EMR-driven stewardship

Feb 01, 2019

Feb 01, 2019

ASP Scan (Weekly) for Feb 01, 2019

Animal stewardship partnership
Antibiotic pipeline details
New PACCARB members
Decline in UK antibiotics
Superbug bloodstream infections in Greece
Antibiotics and malaria prevention
Promising antifungal candidate
Proposed UN AMR guidance
Proposed UN AMR guidance
Antibiotic use in nursing homes
Novel antibiotic vs C diff
Pharmacist interventions
Antibiotics for asthma attack

Apr 05, 2012

Apr 05, 2012

Study: Lax response spurred England's late, severe H1N1 spike

(CIDRAP News) – Lapses in health measures during the second season that the 2009 H1N1 flu virus circulated in England probably contributed to a heavier disease burden—marked by more deaths and hospitalizations—than during the 2009-10 pandemic, researchers reported today.

May 20, 2009

May 20, 2009

H1N1 FLU BREAKING NEWS: Cases top 10,000, businesses activating pandemic plans, vaccine news, military's steps, NYC school closings

The global number of novel H1N1 cases rose to 10,243 in 41 countries, the World Health Organization (WHO) reported today. The count includes 3,648 cases and 72 deaths from Mexico, 5,469 cases and 6 deaths in the United States as of yesterday, 496 cases and 1 death in Canada, and 9 cases and 1 death in Costa Rica. Greece was the only new country added to the list, with a report of one case.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Oct 13, 2005

Oct 13, 2005

Tests confirm H5N1 in Turkey, H5 in Romania

(CIDRAP News) – The avian influenza virus long established in Southeast Asia has reached Europe's doorstep, with confirmation today that a lethal virus in Turkey is H5N1 and that an H5 strain in Romania is still being subtyped.

by country

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»